SSGJ-707
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
SSGJ-707 is a bispecific, recombinant humanized IgG4 monoclonal antibody inhibitor targeting PD-1 and VEGF. SSGJ-707 can be used for cancers research, such as advanced non-small cell lung cancer (NSCLC) and recurrent endometrial cancer[1]
12352005
PD-1/PD-L1; VEGFR
Immunology/Inflammation; Protein Tyrosine Kinase/RTK
Cancer-Kinase/protease
Cancer
98.6
[SSGJ-707]
(241.16 kDa)
[1]Wu L, et al. A phase II trial to evaluate the safety and efficacy of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, as a monotherapy in patients with advanced NSCLC[J]. 2025.
Dry Ice
Store at -80°C for 2 years
http://file.medchemexpress.com/batch_PDF/HY-P991628/SSGJ-707-SDS-MedChemExpress.pdf
Inhibitory Antibodies
No Development Reported
Beschrijving
SSGJ-707 is a bispecific, recombinant humanized IgG4 monoclonal antibody inhibitor targeting PD-1 and VEGF. SSGJ-707 can be used for cancers research, such as a
Specificaties
Recent bekeken producten
AGPAT4 Antibody
MBS7124622-01
0.05 mL
H&E Mount, Permanent Mountindg media for coverslipping H&E stains from water,
NB315
125 mL
SCD polyclonal antibody
GTR18043932-01
50 μL
(KO Validated) SUMO1 Polyclonal Antibody
E-AB-92410-01
60 µL
Salicylate hydroxylase, Microorganism
HY-E70520-01
1 KU
Purified Diphtheria Toxoid protein (cGMP/USP, vaccine grade, ~1500-2500 Lf/ml; Low endotoxin)
DTOX16-N-500
500 µg
BioCoupler® Glass Set (16 oz) x12
BCS1612
12 Each
BioCoupler® x 48
BC48
48 Each